| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 19 | 2024 | 517 | 5.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 19 | 2023 | 436 | 4.990 |
Why?
|
| Cardiac Surgical Procedures | 24 | 2023 | 1117 | 4.110 |
Why?
|
| Aortic Valve | 14 | 2023 | 443 | 2.850 |
Why?
|
| Heart Valve Prosthesis | 9 | 2022 | 301 | 2.760 |
Why?
|
| Patient Readmission | 10 | 2024 | 385 | 2.530 |
Why?
|
| Myocardial Infarction | 7 | 2022 | 1046 | 2.490 |
Why?
|
| Bioprosthesis | 3 | 2023 | 113 | 1.770 |
Why?
|
| Postoperative Complications | 19 | 2024 | 3067 | 1.690 |
Why?
|
| Mitral Valve | 11 | 2022 | 249 | 1.690 |
Why?
|
| Coronary Artery Disease | 8 | 2024 | 800 | 1.640 |
Why?
|
| Aortic Valve Stenosis | 8 | 2022 | 334 | 1.520 |
Why?
|
| Aortic Aneurysm | 3 | 2020 | 237 | 1.520 |
Why?
|
| Heart-Assist Devices | 5 | 2024 | 1025 | 1.340 |
Why?
|
| Surgeons | 3 | 2023 | 257 | 1.290 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2021 | 143 | 1.130 |
Why?
|
| Treatment Outcome | 37 | 2023 | 12363 | 1.130 |
Why?
|
| Endocarditis | 2 | 2021 | 106 | 1.120 |
Why?
|
| Aortic Aneurysm, Thoracic | 5 | 2019 | 664 | 1.100 |
Why?
|
| Heart Failure | 8 | 2024 | 2297 | 1.070 |
Why?
|
| Heart Ventricles | 8 | 2022 | 769 | 1.020 |
Why?
|
| Prosthesis Failure | 2 | 2017 | 158 | 1.020 |
Why?
|
| Ventricular Remodeling | 3 | 2022 | 184 | 1.000 |
Why?
|
| Machine Learning | 4 | 2024 | 251 | 1.000 |
Why?
|
| Risk Assessment | 15 | 2022 | 3444 | 0.990 |
Why?
|
| Aged | 43 | 2024 | 19830 | 0.980 |
Why?
|
| Transcatheter Aortic Valve Replacement | 5 | 2022 | 199 | 0.960 |
Why?
|
| Humans | 90 | 2024 | 124700 | 0.930 |
Why?
|
| Hypersensitivity | 2 | 2017 | 185 | 0.930 |
Why?
|
| Heart Transplantation | 2 | 2021 | 855 | 0.920 |
Why?
|
| Risk Factors | 28 | 2022 | 10249 | 0.910 |
Why?
|
| Thoracic Surgery | 3 | 2022 | 159 | 0.900 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2022 | 160 | 0.890 |
Why?
|
| Length of Stay | 5 | 2024 | 1305 | 0.810 |
Why?
|
| Anticoagulants | 5 | 2023 | 592 | 0.760 |
Why?
|
| Health Care Costs | 4 | 2017 | 369 | 0.750 |
Why?
|
| Middle Aged | 37 | 2024 | 26884 | 0.750 |
Why?
|
| Retrospective Studies | 29 | 2024 | 16262 | 0.740 |
Why?
|
| Patient Discharge | 3 | 2024 | 489 | 0.740 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2022 | 254 | 0.720 |
Why?
|
| Myocardial Revascularization | 2 | 2021 | 103 | 0.710 |
Why?
|
| Coronary Vessels | 3 | 2021 | 555 | 0.710 |
Why?
|
| Hospital Costs | 4 | 2017 | 178 | 0.700 |
Why?
|
| Pericardial Window Techniques | 1 | 2020 | 6 | 0.690 |
Why?
|
| Endocarditis, Bacterial | 1 | 2021 | 134 | 0.680 |
Why?
|
| Time Factors | 19 | 2024 | 6323 | 0.680 |
Why?
|
| Hernia, Abdominal | 1 | 2020 | 18 | 0.670 |
Why?
|
| Aftercare | 2 | 2021 | 146 | 0.670 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 86 | 0.660 |
Why?
|
| Pericardial Effusion | 1 | 2020 | 64 | 0.660 |
Why?
|
| Male | 54 | 2024 | 61314 | 0.660 |
Why?
|
| Hospitals | 2 | 2022 | 386 | 0.660 |
Why?
|
| Costs and Cost Analysis | 3 | 2018 | 162 | 0.650 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2019 | 11 | 0.640 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2017 | 805 | 0.640 |
Why?
|
| Sternotomy | 2 | 2019 | 42 | 0.620 |
Why?
|
| Virginia | 7 | 2017 | 20 | 0.620 |
Why?
|
| Quality of Life | 3 | 2016 | 1936 | 0.610 |
Why?
|
| Extracellular Vesicles | 1 | 2019 | 46 | 0.610 |
Why?
|
| Ticks | 1 | 2018 | 30 | 0.610 |
Why?
|
| Consumer Health Information | 1 | 2018 | 25 | 0.600 |
Why?
|
| Dependovirus | 1 | 2019 | 128 | 0.600 |
Why?
|
| Mortality | 2 | 2017 | 238 | 0.600 |
Why?
|
| Secondary Prevention | 1 | 2020 | 217 | 0.600 |
Why?
|
| Stroke | 3 | 2024 | 986 | 0.600 |
Why?
|
| Female | 51 | 2024 | 66570 | 0.580 |
Why?
|
| Methylene Blue | 1 | 2017 | 13 | 0.560 |
Why?
|
| Internship and Residency | 4 | 2021 | 1175 | 0.560 |
Why?
|
| Educational Measurement | 1 | 2020 | 323 | 0.550 |
Why?
|
| Vasoplegia | 1 | 2017 | 11 | 0.550 |
Why?
|
| Survival Rate | 11 | 2020 | 2055 | 0.550 |
Why?
|
| Troponin I | 1 | 2018 | 104 | 0.550 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2018 | 149 | 0.550 |
Why?
|
| Quality Indicators, Health Care | 2 | 2018 | 218 | 0.540 |
Why?
|
| Hospital Mortality | 11 | 2022 | 1022 | 0.540 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2019 | 449 | 0.540 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 207 | 0.540 |
Why?
|
| Lung Transplantation | 1 | 2020 | 320 | 0.530 |
Why?
|
| Heart Valve Diseases | 2 | 2016 | 173 | 0.530 |
Why?
|
| Disaccharides | 1 | 2016 | 14 | 0.530 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 183 | 0.520 |
Why?
|
| Acute Kidney Injury | 3 | 2022 | 635 | 0.520 |
Why?
|
| Palliative Care | 1 | 2020 | 429 | 0.510 |
Why?
|
| Propensity Score | 4 | 2024 | 216 | 0.500 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2016 | 41 | 0.500 |
Why?
|
| Prosthesis Design | 5 | 2023 | 681 | 0.500 |
Why?
|
| Erythropoietin | 1 | 2016 | 106 | 0.480 |
Why?
|
| Postoperative Care | 1 | 2017 | 300 | 0.470 |
Why?
|
| Calcium | 1 | 2019 | 1101 | 0.460 |
Why?
|
| Proportional Hazards Models | 6 | 2018 | 1357 | 0.460 |
Why?
|
| United States | 13 | 2024 | 10866 | 0.450 |
Why?
|
| Thoracotomy | 1 | 2015 | 111 | 0.440 |
Why?
|
| Marfan Syndrome | 1 | 2016 | 141 | 0.440 |
Why?
|
| Databases, Factual | 7 | 2021 | 1176 | 0.440 |
Why?
|
| Patient Selection | 5 | 2020 | 697 | 0.410 |
Why?
|
| Thrombosis | 1 | 2017 | 526 | 0.400 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2020 | 1052 | 0.400 |
Why?
|
| Atherosclerosis | 1 | 2019 | 920 | 0.380 |
Why?
|
| Reoperation | 4 | 2020 | 830 | 0.370 |
Why?
|
| Aorta, Thoracic | 2 | 2015 | 531 | 0.370 |
Why?
|
| Myocardium | 3 | 2022 | 1019 | 0.360 |
Why?
|
| Endovascular Procedures | 2 | 2017 | 737 | 0.350 |
Why?
|
| Linear Models | 3 | 2017 | 682 | 0.350 |
Why?
|
| Tricuspid Valve | 2 | 2009 | 60 | 0.340 |
Why?
|
| Leiomyosarcoma | 1 | 2009 | 28 | 0.330 |
Why?
|
| Recovery of Function | 3 | 2023 | 445 | 0.330 |
Why?
|
| Incidence | 7 | 2020 | 3115 | 0.330 |
Why?
|
| Aged, 80 and over | 11 | 2016 | 6584 | 0.320 |
Why?
|
| Heart Arrest, Induced | 3 | 2020 | 75 | 0.310 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 5154 | 0.300 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 344 | 0.300 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2021 | 201 | 0.290 |
Why?
|
| Cerebral Revascularization | 1 | 2007 | 21 | 0.280 |
Why?
|
| Survivors | 1 | 2009 | 337 | 0.280 |
Why?
|
| Observer Variation | 2 | 2018 | 299 | 0.280 |
Why?
|
| Hemorrhage | 2 | 2013 | 468 | 0.270 |
Why?
|
| Coronary Aneurysm | 1 | 2007 | 32 | 0.270 |
Why?
|
| Cardiac Catheterization | 3 | 2016 | 634 | 0.270 |
Why?
|
| Logistic Models | 4 | 2018 | 1807 | 0.260 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2006 | 63 | 0.260 |
Why?
|
| Preoperative Care | 3 | 2018 | 355 | 0.260 |
Why?
|
| Comorbidity | 4 | 2022 | 1530 | 0.250 |
Why?
|
| Prognosis | 5 | 2020 | 4620 | 0.250 |
Why?
|
| Age Factors | 5 | 2018 | 2807 | 0.240 |
Why?
|
| Obesity | 1 | 2017 | 2248 | 0.240 |
Why?
|
| Neoplasms | 1 | 2020 | 2780 | 0.240 |
Why?
|
| Heart | 2 | 2020 | 729 | 0.240 |
Why?
|
| Surgical Wound Infection | 2 | 2017 | 260 | 0.240 |
Why?
|
| Aorta | 3 | 2018 | 547 | 0.240 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2005 | 77 | 0.240 |
Why?
|
| Animals | 14 | 2022 | 34234 | 0.230 |
Why?
|
| Stomach Ulcer | 1 | 2005 | 93 | 0.230 |
Why?
|
| Adult | 12 | 2021 | 29555 | 0.230 |
Why?
|
| Gastrostomy | 1 | 2005 | 84 | 0.220 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 612 | 0.220 |
Why?
|
| Catheterization | 2 | 2018 | 234 | 0.220 |
Why?
|
| Rats | 2 | 2021 | 3728 | 0.220 |
Why?
|
| Sheep | 6 | 2012 | 220 | 0.220 |
Why?
|
| Motion | 1 | 2023 | 43 | 0.210 |
Why?
|
| Clinical Competence | 2 | 2023 | 996 | 0.210 |
Why?
|
| Survival Analysis | 2 | 2018 | 1504 | 0.210 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 19 | 0.210 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 24 | 0.210 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 588 | 0.210 |
Why?
|
| MicroRNAs | 2 | 2022 | 838 | 0.210 |
Why?
|
| Anastomosis, Surgical | 1 | 2023 | 173 | 0.200 |
Why?
|
| Enteral Nutrition | 1 | 2005 | 256 | 0.200 |
Why?
|
| Hand | 1 | 2023 | 100 | 0.200 |
Why?
|
| Alveolar Bone Loss | 1 | 2022 | 2 | 0.200 |
Why?
|
| Atrial Appendage | 1 | 2022 | 46 | 0.200 |
Why?
|
| Periodontitis | 1 | 2022 | 11 | 0.200 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2018 | 355 | 0.200 |
Why?
|
| Registries | 3 | 2020 | 1428 | 0.190 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 2900 | 0.190 |
Why?
|
| Biocompatible Materials | 1 | 2022 | 119 | 0.190 |
Why?
|
| Cardioplegic Solutions | 2 | 2020 | 17 | 0.190 |
Why?
|
| Gastric Mucosa | 1 | 2005 | 487 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2005 | 476 | 0.190 |
Why?
|
| Mesothelioma | 1 | 2022 | 88 | 0.180 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2021 | 11 | 0.180 |
Why?
|
| Monitoring, Intraoperative | 1 | 2021 | 133 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 920 | 0.180 |
Why?
|
| Alginates | 1 | 2020 | 18 | 0.180 |
Why?
|
| Biomarkers | 3 | 2019 | 3083 | 0.180 |
Why?
|
| Organ Preservation | 1 | 2020 | 45 | 0.170 |
Why?
|
| Prosthesis Implantation | 2 | 2020 | 141 | 0.170 |
Why?
|
| Preoperative Period | 2 | 2017 | 88 | 0.170 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 153 | 0.170 |
Why?
|
| Embolectomy | 1 | 2020 | 8 | 0.170 |
Why?
|
| Hydrogels | 1 | 2021 | 84 | 0.170 |
Why?
|
| Hemodynamics | 3 | 2020 | 852 | 0.170 |
Why?
|
| Algorithms | 3 | 2021 | 1625 | 0.170 |
Why?
|
| Perfusion | 1 | 2020 | 207 | 0.160 |
Why?
|
| Mitochondria | 1 | 2024 | 684 | 0.160 |
Why?
|
| Shock, Cardiogenic | 1 | 2021 | 192 | 0.160 |
Why?
|
| Thorax | 1 | 2019 | 71 | 0.160 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 227 | 0.160 |
Why?
|
| Aorta, Abdominal | 1 | 2020 | 126 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 1290 | 0.160 |
Why?
|
| Odds Ratio | 3 | 2017 | 1253 | 0.160 |
Why?
|
| Cohort Studies | 6 | 2020 | 4799 | 0.160 |
Why?
|
| Postoperative Period | 3 | 2020 | 333 | 0.160 |
Why?
|
| Medicare | 1 | 2022 | 424 | 0.160 |
Why?
|
| Frailty | 1 | 2021 | 106 | 0.160 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2021 | 113 | 0.160 |
Why?
|
| Access to Information | 1 | 2018 | 40 | 0.150 |
Why?
|
| Health Communication | 1 | 2018 | 25 | 0.150 |
Why?
|
| Cell Survival | 1 | 2021 | 812 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2005 | 832 | 0.150 |
Why?
|
| Cost Savings | 2 | 2017 | 71 | 0.150 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 215 | 0.150 |
Why?
|
| Sex Factors | 3 | 2018 | 1287 | 0.150 |
Why?
|
| Mediastinitis | 1 | 2017 | 14 | 0.150 |
Why?
|
| Wearable Electronic Devices | 1 | 2019 | 105 | 0.150 |
Why?
|
| Acute Disease | 2 | 2020 | 1107 | 0.140 |
Why?
|
| Hyperglycemia | 2 | 2017 | 225 | 0.140 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 659 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 177 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2018 | 89 | 0.140 |
Why?
|
| Meat | 1 | 2017 | 48 | 0.140 |
Why?
|
| Transfection | 1 | 2019 | 1069 | 0.140 |
Why?
|
| Multilevel Analysis | 1 | 2017 | 8 | 0.140 |
Why?
|
| Perception | 1 | 2018 | 219 | 0.140 |
Why?
|
| Echocardiography | 4 | 2016 | 1053 | 0.140 |
Why?
|
| Career Choice | 1 | 2018 | 146 | 0.140 |
Why?
|
| Emergencies | 1 | 2018 | 170 | 0.130 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 461 | 0.130 |
Why?
|
| Lung | 2 | 2023 | 1496 | 0.130 |
Why?
|
| Learning Curve | 1 | 2017 | 53 | 0.130 |
Why?
|
| Psoas Muscles | 1 | 2016 | 5 | 0.130 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 119 | 0.130 |
Why?
|
| Walk Test | 1 | 2016 | 24 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2023 | 2092 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2018 | 195 | 0.130 |
Why?
|
| Tomography | 2 | 2009 | 41 | 0.130 |
Why?
|
| Disease Progression | 2 | 2015 | 2058 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 897 | 0.120 |
Why?
|
| Sarcopenia | 1 | 2016 | 42 | 0.120 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 41 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2018 | 492 | 0.120 |
Why?
|
| Genetic Therapy | 1 | 2019 | 687 | 0.120 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2017 | 546 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2016 | 189 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 185 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2885 | 0.110 |
Why?
|
| Cost of Illness | 1 | 2016 | 247 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 579 | 0.110 |
Why?
|
| Cause of Death | 1 | 2016 | 474 | 0.110 |
Why?
|
| Clostridium Infections | 1 | 2017 | 243 | 0.110 |
Why?
|
| Overweight | 1 | 2017 | 364 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2015 | 1191 | 0.110 |
Why?
|
| Radial Artery | 1 | 2013 | 28 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 1660 | 0.100 |
Why?
|
| Stents | 2 | 2017 | 887 | 0.100 |
Why?
|
| Quality Improvement | 2 | 2019 | 639 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2015 | 312 | 0.100 |
Why?
|
| Inflammation | 1 | 2019 | 1440 | 0.100 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2011 | 8 | 0.090 |
Why?
|
| Heart Function Tests | 2 | 2012 | 57 | 0.090 |
Why?
|
| Massachusetts | 1 | 2011 | 126 | 0.090 |
Why?
|
| Ligation | 2 | 2012 | 135 | 0.090 |
Why?
|
| Prostheses and Implants | 1 | 2012 | 152 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1260 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 726 | 0.090 |
Why?
|
| End Stage Liver Disease | 1 | 2013 | 181 | 0.090 |
Why?
|
| Liver | 2 | 2009 | 1742 | 0.090 |
Why?
|
| Hypertension, Portal | 1 | 2011 | 78 | 0.090 |
Why?
|
| Elective Surgical Procedures | 1 | 2011 | 160 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2014 | 351 | 0.080 |
Why?
|
| Heart Valves | 1 | 2009 | 51 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2009 | 47 | 0.080 |
Why?
|
| Histocytochemistry | 1 | 2009 | 100 | 0.080 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2008 | 240 | 0.080 |
Why?
|
| Capsule Endoscopy | 1 | 2009 | 20 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2008 | 759 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2013 | 691 | 0.080 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2009 | 42 | 0.080 |
Why?
|
| Microscopy | 1 | 2009 | 119 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 88 | 0.080 |
Why?
|
| Hospitalization | 1 | 2017 | 1775 | 0.080 |
Why?
|
| Hypertension | 1 | 2017 | 1329 | 0.080 |
Why?
|
| Cardiac Output | 1 | 2008 | 171 | 0.070 |
Why?
|
| ROC Curve | 1 | 2009 | 568 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 144 | 0.070 |
Why?
|
| Hyperkalemia | 1 | 2008 | 66 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2011 | 365 | 0.070 |
Why?
|
| Time | 1 | 2007 | 92 | 0.070 |
Why?
|
| Sugar Alcohols | 1 | 2006 | 3 | 0.070 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2006 | 7 | 0.070 |
Why?
|
| Liver Transplantation | 2 | 2013 | 1031 | 0.070 |
Why?
|
| Models, Animal | 1 | 2008 | 465 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3154 | 0.060 |
Why?
|
| Operative Time | 2 | 2017 | 166 | 0.060 |
Why?
|
| Sutures | 1 | 2006 | 65 | 0.060 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 19 | 0.060 |
Why?
|
| Rifamycins | 1 | 2006 | 21 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 82 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 97 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 2417 | 0.060 |
Why?
|
| Hepatic Encephalopathy | 1 | 2006 | 75 | 0.060 |
Why?
|
| Liver Failure | 1 | 2006 | 89 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 369 | 0.060 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 290 | 0.060 |
Why?
|
| Cartilage, Articular | 1 | 2005 | 57 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 1 | 2024 | 107 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1872 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2012 | 4396 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 508 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2007 | 676 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1327 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 1415 | 0.050 |
Why?
|
| Porphyromonas gingivalis | 1 | 2022 | 1 | 0.050 |
Why?
|
| Treponema denticola | 1 | 2022 | 2 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2005 | 128 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2022 | 244 | 0.050 |
Why?
|
| Mediastinum | 1 | 2022 | 42 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 9022 | 0.050 |
Why?
|
| Osteoarthritis, Knee | 1 | 2005 | 244 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 116 | 0.050 |
Why?
|
| Ophthalmoscopes | 1 | 2001 | 4 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2007 | 1369 | 0.050 |
Why?
|
| Research Design | 1 | 2005 | 692 | 0.050 |
Why?
|
| Ophthalmoscopy | 1 | 2001 | 28 | 0.050 |
Why?
|
| Wrist | 1 | 2021 | 24 | 0.050 |
Why?
|
| Accreditation | 1 | 2021 | 88 | 0.050 |
Why?
|
| Creatinine | 1 | 2022 | 391 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 174 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2022 | 375 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2005 | 522 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2017 | 6132 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2021 | 103 | 0.040 |
Why?
|
| Fear | 1 | 2021 | 200 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 360 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 134 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2020 | 111 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 1958 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 265 | 0.040 |
Why?
|
| Adolescent | 1 | 2016 | 19216 | 0.040 |
Why?
|
| Direct Service Costs | 1 | 2017 | 8 | 0.040 |
Why?
|
| Walking | 1 | 2019 | 212 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 402 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 458 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 1286 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 287 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 515 | 0.030 |
Why?
|
| Benchmarking | 1 | 2017 | 134 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 504 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 397 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 715 | 0.030 |
Why?
|
| Mice | 2 | 2022 | 17644 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2016 | 96 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 436 | 0.030 |
Why?
|
| Morbidity | 1 | 2015 | 248 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2015 | 68 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 505 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 778 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 442 | 0.030 |
Why?
|
| Punctures | 1 | 2013 | 55 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2017 | 492 | 0.030 |
Why?
|
| Cardiac Tamponade | 1 | 2012 | 36 | 0.020 |
Why?
|
| Sheep, Domestic | 1 | 2012 | 17 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 810 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2016 | 1136 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 97 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2015 | 538 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2013 | 227 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2015 | 541 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2013 | 444 | 0.020 |
Why?
|
| Transcriptome | 1 | 2017 | 953 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1708 | 0.020 |
Why?
|
| HIV | 1 | 2011 | 179 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3292 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2012 | 312 | 0.020 |
Why?
|
| Heart Septum | 1 | 2008 | 54 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2008 | 56 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 400 | 0.020 |
Why?
|
| Diastole | 1 | 2008 | 175 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2008 | 196 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2007 | 112 | 0.020 |
Why?
|
| Fatty Acids, Essential | 1 | 2006 | 5 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2006 | 101 | 0.020 |
Why?
|
| Nutritional Requirements | 1 | 2006 | 181 | 0.020 |
Why?
|
| Birefringence | 1 | 2005 | 11 | 0.010 |
Why?
|
| Swine | 1 | 2008 | 1210 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2005 | 74 | 0.010 |
Why?
|
| Computer Systems | 1 | 2005 | 37 | 0.010 |
Why?
|
| Collagen | 1 | 2005 | 318 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 584 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 1113 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3561 | 0.010 |
Why?
|
| Macula Lutea | 1 | 2001 | 45 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 2001 | 139 | 0.010 |
Why?
|
| Eye Diseases | 1 | 2001 | 119 | 0.010 |
Why?
|
| Equipment Design | 1 | 2001 | 598 | 0.010 |
Why?
|
| Retina | 1 | 2001 | 450 | 0.010 |
Why?
|
| Cornea | 1 | 2001 | 652 | 0.010 |
Why?
|